Rising demand for preventive medicines is the key factor for escalating the circulating tumor cell diagnostics market size during the forecast time line. Advancement in multiple tumor markers which can be utilized together with companion diagnostics to monitor and detect various forms of cancer will further boost the industry revenue.
Increasing incidences of oncology diseases along with the introduction of novel biotechnological techniques that will enable quantitation and isolation of circulating tumor cells. In addition, other contributing factors for improving industry growth rate include cost savings on multiple treatments, early detetction of disease, patient compliance, and drug safety.
Global circulating tumor cell diagnostics market is segmented based on the technology as, CTC Enrichment Methods, CTC Detection Methods, and CTC Analysis. On the basis of application, the global circulating tumor cell diagnostics market is segregated as Cancer Cell Research, EMT Biomarkers Development, and Tumorigenesis Research. Cancer Cell Research is expected to witness notable gains in the forecast years.
Global circulating tumor cell diagnostics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional circulating tumor cell diagnostics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global circulating tumor cell diagnostics market share consists of several players including Advanced Cell Diagnostics, Janssen Diagnostics, Biocept Inc., ScreenCell, Silicon Biosystems, Aviva Biosciences, Biofluidica Inc., CellTraffix Inc., Fluxion Biosciences Inc., Sysmex Corporation, Epic Sciences Inc., Clearbridge BioMedics Pte Ltd, and Greiner Bio-One GmbH.
The Circulating Tumor Cell Diagnostics Market has been segmented as below:
Circulating Tumor Cell Diagnostics Market, By Technology
Circulating Tumor Cell Diagnostics Market, By Application
Circulating Tumor Cell Diagnostics Market, By Region
The report covers:
Report scope:
The global circulating tumor cell diagnostics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Advanced Cell Diagnostics, Janssen Diagnostics, Biocept Inc., ScreenCell, Silicon Biosystems, Aviva Biosciences, Biofluidica Inc., CellTraffix Inc., Fluxion Biosciences Inc., Sysmex Corporation, Epic Sciences Inc., Clearbridge BioMedics Pte Ltd, and Greiner Bio-One GmbH.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Immunofluorescence Analyzers market
Veterinary/Animal Vaccines Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Medical need for cancer diagnostics
4.2.2. Potential applications of CTC in cancer management
4.3. Restraints
4.3.1. Rare occurrence of circulating tumor cells
4.3.2. Lack of consistency in detection and enrichment methods
4.4. Opportunities
4.4.1. Growing cancer incidence
4.4.2. Rising demand for preventive medicine & companion diagnostics
4.4.3. Development of cluster chip technology
4.5. Challenges
4.5.1. Higher preference of point-of-care testing and absence of POC adaptable CTC
5. Circulating Tumor Cell Diagnostics Market, By Technology
5.1. Key Points
5.2. CTC Enrichment
5.2.1. Ex-vivo positive selection
5.2.2. In-vivo positive selection
5.2.3. Negative selection
5.2.4. Microchips
5.2.5. Single spiral micro channel
5.3. CTC Detection
5.3.1. Immunocytochemical technologies
5.3.2. Molecular (RNA) based technologies
5.3.3. EPISPOT functional in-vitro cell culture
5.3.4. Functional in-vitro cell invasion assay
5.3.5. Xenotransplantation models
5.4. CTC Analysis
6. Circulating Tumor Cell Diagnostics Market, By Application
6.1. Key Points
6.2. Tumorigenesis research
6.3. EMT biomarkers development
6.4. Cancer stem cell research
6.5. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. Advanced Cell Diagnostics
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Janssen Diagnostics
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. Biocept Inc.
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. ScreenCell, Silicon Biosystems
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Aviva Biosciences
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Biofluidica Inc.
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. CellTraffix Inc.
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Fluxion Biosciences Inc.
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Sysmex Corporation
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
8.10. Epic Sciences Inc.
8.10.1. Company Overview
8.10.2. Product/Service Landscape
8.10.3. Financial Overview
8.10.4. Recent Developments
8.11. Clearbridge BioMedics Pte Ltd
8.11.1. Company Overview
8.11.2. Product/Service Landscape
8.11.3. Financial Overview
8.11.4. Recent Developments
8.12. Greiner Bio-One GmbH
8.12.1. Company Overview
8.12.2. Product/Service Landscape
8.12.3. Financial Overview
8.12.4. Recent Developments
The Circulating Tumor Cell Diagnostics Market has been segmented as below:
Circulating Tumor Cell Diagnostics Market, By Technology
Circulating Tumor Cell Diagnostics Market, By Application
Circulating Tumor Cell Diagnostics Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
